Company / EPS (Diluted)
Tonix Pharmaceuticals Holding Corp. EPS (Diluted) History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$176.60
FY2025
5-year range
-$14720.25 / -$20.01
FY2023-FY2025
Trend
+98.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $-20.01 to $-176.60 over the past 2 years.
Based on SEC 10-K filings.
-176.60 in FY2025.
Declined from $-20.01 to $-176.60 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (diluted) increased 98.8% year-over-year.
Company context
Key Data Points
- Altman Z-Score -0.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$176.60 | +98.8% |
| FY2024 | -$14720.25 | -73464.5% |
| FY2023 | -$20.01 | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 28, 2026